Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB, Immune Assays Team, Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, United States Government (USG)/CoVPN Biostatistics Team

Open source

DOI: 10.1038/s41467-024-53727-y
Published: 2024 Nov 12
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-53727-y,
  title = {Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.},
  author = {Carpp LN and Hyrien O and Fong Y and Benkeser D and Roels S and Stieh DJ and Van Dromme I and Van Roey GA and Kenny A and Huang Y and Carone M and McDermott AB and Houchens CR and Martins K and Jayashankar L and Castellino F and Amoa-Awua O and Basappa M and Flach B and Lin BC and Moore C and Naisan M and Naqvi M and Narpala S and O'Connell S and Mueller A and Serebryannyy L and Castro M and Wang J and Petropoulos CJ and Luedtke A and Lu Y and Yu C and Juraska M and Hejazi NS and Wolfe DN and Sadoff J and Gray GE and Grinsztejn B and Goepfert PA and Bekker LG and Gaur AH and Veloso VG and Randhawa AK and Andrasik MP and Hendriks J and Truyers C and Vandebosch A and Struyf F and Schuitemaker H and Douoguih M and Kublin JG and Corey L and Neuzil KM and Follmann D and Koup RA and Donis RO and Gilbert PB and Immune Assays Team and Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team and United States Government (USG)/CoVPN Biostatistics Team},
  year = {2024},
  journal = {Nature communications},
  doi = {10.1038/s41467-024-53727-y},
  url = {https://doi.org/10.1038/s41467-024-53727-y}
}

RIS

TY  - JOUR
TI  - Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
AU  - Carpp LN
AU  - Hyrien O
AU  - Fong Y
AU  - Benkeser D
AU  - Roels S
AU  - Stieh DJ
AU  - Van Dromme I
AU  - Van Roey GA
AU  - Kenny A
AU  - Huang Y
AU  - Carone M
AU  - McDermott AB
AU  - Houchens CR
AU  - Martins K
AU  - Jayashankar L
AU  - Castellino F
AU  - Amoa-Awua O
AU  - Basappa M
AU  - Flach B
AU  - Lin BC
AU  - Moore C
AU  - Naisan M
AU  - Naqvi M
AU  - Narpala S
AU  - O'Connell S
AU  - Mueller A
AU  - Serebryannyy L
AU  - Castro M
AU  - Wang J
AU  - Petropoulos CJ
AU  - Luedtke A
AU  - Lu Y
AU  - Yu C
AU  - Juraska M
AU  - Hejazi NS
AU  - Wolfe DN
AU  - Sadoff J
AU  - Gray GE
AU  - Grinsztejn B
AU  - Goepfert PA
AU  - Bekker LG
AU  - Gaur AH
AU  - Veloso VG
AU  - Randhawa AK
AU  - Andrasik MP
AU  - Hendriks J
AU  - Truyers C
AU  - Vandebosch A
AU  - Struyf F
AU  - Schuitemaker H
AU  - Douoguih M
AU  - Kublin JG
AU  - Corey L
AU  - Neuzil KM
AU  - Follmann D
AU  - Koup RA
AU  - Donis RO
AU  - Gilbert PB
AU  - Immune Assays Team
AU  - Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team
AU  - United States Government (USG)/CoVPN Biostatistics Team
PY  - 2024
JO  - Nature communications
DO  - 10.1038/s41467-024-53727-y
UR  - https://doi.org/10.1038/s41467-024-53727-y
ER  -

APA

LN, C., O, H., Y, F., D, B., S, R., DJ, S., I, V. D., GA, V. R., A, K., Y, H., M, C., AB, M., CR, H., K, M., L, J., F, C., O, A., M, B., B, F., BC, L., C, M., M, N., M, N., S, N., S, O., A, M., L, S., M, C., J, W., CJ, P., A, L., Y, L., C, Y., M, J., NS, H., DN, W., J, S., GE, G., B, G., PA, G., LG, B., AH, G., VG, V., AK, R., MP, A., J, H., C, T., A, V., F, S., H, S., M, D., JG, K., L, C., KM, N., D, F., RA, K., RO, D., PB, G., Team, I. A., Team, C. V. P. N. (., & Team, U. S. G. (. B. (2024). Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.. Nature communications. https://doi.org/10.1038/s41467-024-53727-y

Source records

pubmed · retrieved 2026-09-26T22:59:19.892Z